Characteristics of Liver Function in Patients With SARS-CoV-2 and Chronic HBV Coinfection

Xiaojing Zou1, Minghao Fang1, Shusheng Li1

  • 1Department of Emergency, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Insights

COVID-19 patients with chronic hepatitis B virus (HBV) coinfection frequently experienced liver injury, which was linked to severe disease and worse outcomes. Frequent liver function monitoring is crucial for these patients.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Coronavirus disease 2019 (COVID-19) poses a significant global health challenge.
  • Hepatitis B virus (HBV) infection is a prevalent chronic condition worldwide.
  • Understanding the interplay between SARS-CoV-2 and chronic HBV is critical for patient management.

Purpose of the Study:

  • To characterize liver function abnormalities in patients coinfected with SARS-CoV-2 and chronic HBV.
  • To investigate the association between liver dysfunction and COVID-19 severity and prognosis in this coinfected population.

Main Methods:

  • A cohort of 105 adult patients with SARS-CoV-2 and chronic HBV coinfection was studied.
  • Demographic, clinical, laboratory, treatment, and outcome data were collected.
  • Liver function tests and their correlation with disease severity and prognosis were analyzed.

Main Results:

  • Elevated liver enzymes and bilirubin were observed in a significant proportion of patients at admission and increased during hospitalization.
  • 13.33% of patients developed liver injury, with 28.57% progressing to acute-on-chronic liver failure.
  • Liver injury was associated with a higher incidence of severe COVID-19, complications, and increased mortality.

Conclusions:

  • Liver injury in SARS-CoV-2/chronic HBV coinfected patients is linked to disease severity and poor prognosis.
  • Close monitoring and frequent evaluation of liver function are essential during COVID-19 treatment for patients with chronic HBV.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
115
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.7K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
145
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
116
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
4.6K
Liver Histology01:27

Liver Histology

The microscopic anatomy of the liver is a complex and intricate system that comprises numerous structural units known as liver lobules, each of which is comparable in size to a sesame seed. These hexagonal structures consist of plates of liver cells or hepatocytes, which are characterized by their versatility and abundance of cellular apparatus like rough and smooth ER, Golgi apparatus, peroxisomes, and mitochondria.
Hepatocytes perform a variety of essential functions. They secrete...
3.8K